PRDI-BF1 and PRDI-BF1P Isoform Expressions Correlate with Disease Status in Multiple Myeloma Patients

Overview

Journal Hematol Rep

Publisher MDPI

Date 2018 Jan 16

PMID 29333224

Citations 1

Authors

Gabriele Buda

Francesca Guerrini

Sara Galimberti

Enrico Orciuolo

Simone Pacini

Elisa Mazzantini

Mario Petrini

Affiliations

Soon will be listed here.

Citing Articles

Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Romero-Garcia R, Gomez-Jaramillo L, Mateos R, Jimenez-Gomez G, Pedreno-Horrillo N, Foncubierta E Sci Rep. 2020; 10(1):15899.

PMID: 32985591 PMC: 7522722. DOI: 10.1038/s41598-020-72946-z.

References

Shapiro-Shelef M, Lin K, Savitsky D, Liao J, Calame K . Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med. 2005; 202(11):1471-6. PMC: 2213334. DOI: 10.1084/jem.20051611. View

Borson N, Lacy M, Wettstein P . Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood. 2002; 100(13):4629-39. DOI: 10.1182/blood.V100.13.4629. View

Kim J, Mathew S, Mathew P . Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells. Immunobiology. 2015; 221(1):31-9. DOI: 10.1016/j.imbio.2015.08.005. View

Ocana E, Gonzalez-Garcia I, Gutierrez N, Mora-Lopez F, Brieva J, Campos-Caro A . The expression of PRDI-BF1 beta isoform in multiple myeloma plasma cells. Haematologica. 2006; 91(11):1579-80. View

Hung K, Su S, Chen C, Hsu P, Huang S, Wu W . Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells. Cell Death Differ. 2016; 23(7):1175-84. PMC: 4946885. DOI: 10.1038/cdd.2015.167. View

Gyory I, Fejer G, Ghosh N, Seto E, Wright K . Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines. J Immunol. 2003; 170(6):3125-33. DOI: 10.4049/jimmunol.170.6.3125. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

Garcia J, Roncador G, Garcia J, Sanz A, Maestre L, Lucas E . PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma. Haematologica. 2006; 91(4):467-74. View

Nagy M, Chapuis B, Matthes T . Expression of transcription factors Pu.1, Spi-B, Blimp-1, BSAP and oct-2 in normal human plasma cells and in multiple myeloma cells. Br J Haematol. 2002; 116(2):429-35. DOI: 10.1046/j.1365-2141.2002.03271.x. View

10.

Klein B, Tarte K, Jourdan M, Mathouk K, Moreaux J, Jourdan E . Survival and proliferation factors of normal and malignant plasma cells. Int J Hematol. 2003; 78(2):106-13. PMC: 2423421. DOI: 10.1007/BF02983377. View

11.

Xia Y, Xu-Monette Z, Tzankov A, Li X, Manyam G, Murty V . Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma. Leukemia. 2016; 31(3):625-636. PMC: 5837859. DOI: 10.1038/leu.2016.243. View

12.

Lin F, Huang S, Hung K, Su S, Chung C, Matsuzawa A . ASK1 promotes apoptosis of normal and malignant plasma cells. Blood. 2012; 120(5):1039-47. DOI: 10.1182/blood-2011-12-399808. View